Xiaocui Zhou
Impact in
-
- Liver Disease Diagnosis and Treatment
Papers in
-
- COVID-19 Clinical Research Studies 2
- Co-authors
- Qiuju Wang (2 shared papers)Yizhe Cui (2 shared papers)Renxu Chang (2 shared papers)Chuang Xu (2 shared papers)Heng Zhang (1 shared paper)Jingjiao Zhou (1 shared paper)Xiaodong Guo (3 shared papers)Yudie Wang (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Frontiers in Immunology (2 papers)Current Drug Targets (1 paper)Vaccine (1 paper)Frontiers in Pharmacology (1 paper)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Xiaocui Zhou
11 papers receiving 298 citations
Peers
Comparison fields: 5 of 74
- Biological Psychiatry 8
- Epidemiology 103
- Infectious Diseases 45
- Rehabilitation 15
- Pharmacology 19
Countries citing papers authored by Xiaocui Zhou
This map shows the geographic impact of Xiaocui Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaocui Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaocui Zhou more than expected).
Fields of papers citing papers by Xiaocui Zhou
This network shows the impact of papers produced by Xiaocui Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaocui Zhou. The network helps show where Xiaocui Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaocui Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 163 | |
| 2 | 2020 | 35 | |
| 3 | 2022 | 22 | |
| 4 | 2019 | 18 | |
| 5 | 2019 | 14 | |
| 6 | 2021 | 12 | |
| 7 | 2018 | 11 | |
| 8 | 2020 | 11 | |
| 9 | 2019 | 8 | |
| 10 | 2022 | 4 | |
| 11 | 2020 | 4 |
About Xiaocui Zhou
Xiaocui Zhou is a scholar working on Molecular Biology, Infectious Diseases, Cardiology and Cardiovascular Medicine, Oncology and Epidemiology, having authored 11 papers that have together received 302 indexed citations. Recurring topics across this work include Cancer Research and Treatments (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), COVID-19 Clinical Research Studies (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (1 paper), Long-Term Effects of COVID-19 (1 paper) and Diet, Metabolism, and Disease (1 paper). The work is most often cited by research in Biological Psychiatry (8 citations), Epidemiology (103 citations), Infectious Diseases (45 citations), Rehabilitation (15 citations) and Pharmacology (19 citations). Xiaocui Zhou has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Qiuju Wang, Yizhe Cui, Renxu Chang, Chuang Xu, Heng Zhang, Jingjiao Zhou, Xiaodong Guo, Yudie Wang, Yu Tian and Juan Huang. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Immunology, Current Drug Targets, Vaccine and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.